Literature DB >> 30714719

Alpha-Synuclein in Peripheral Tissues in Parkinson's Disease.

Ling-Yan Ma1,2, Gen-Liang Liu1,2, Dong-Xu Wang1,2, Mei-Mei Zhang1,2, Wen-Yi Kou1,2, Tao Feng1,2,3.   

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder. To date, the diagnosis of PD relies mainly on clinical manifestations whereas neuropathological confirmation of the brain is only possible with postmortem studies. Neuronal loss in the substantia nigra pars compacta (SNc) associated with Lewy bodies/neurites is the pathological hallmark feature of PD. The major component of Lewy pathology (LP) is misfolded alpha-synuclein (α-SYN). There is evidence that the distribution of LP is not only limited to the brain but extends to peripheral tissues, including gastrointestinal tract, salivary glands, olfactory mucosa, skin, retina, adrenal gland, and heart. Sensitivity and specificity of α-SYN detection in PD vary greatly among studies due to methodological heterogeneity, such as sampling sites and size, tissue preparation, staining techniques, and antibodies used. Of note, α-SYN has also been found in preclinical and prodromal PD. Further in vivo studies focusing on favorable biopsy sites and standard techniques are needed to get better understanding of α-SYN deposits in preclinical, prodromal, and clinical PD.

Entities:  

Keywords:  Alpha-synuclein; Parkinson’s disease; peripheral tissues

Mesh:

Substances:

Year:  2019        PMID: 30714719     DOI: 10.1021/acschemneuro.8b00383

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  12 in total

1.  Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDAC.

Authors:  Amandine Rovini; Philip A Gurnev; Alexandra Beilina; María Queralt-Martín; William Rosencrans; Mark R Cookson; Sergey M Bezrukov; Tatiana K Rostovtseva
Journal:  Cell Mol Life Sci       Date:  2019-11-23       Impact factor: 9.261

Review 2.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

3.  Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson's Disease.

Authors:  Brady T Mannett; Braden C Capt; Krista Pearman; Lori M Buhlman; John M VandenBrooks; Gerald B Call
Journal:  Parkinsons Dis       Date:  2022-07-08

4.  Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson's disease.

Authors:  Achim Thomzig; Katja Wagenführ; Phillip Pinder; Marion Joncic; Walter J Schulz-Schaeffer; Michael Beekes
Journal:  Acta Neuropathol       Date:  2021-04-24       Impact factor: 17.088

5.  Oral Mucosa Derived α-Synuclein as a Potential Diagnostic Biomarker for Parkinson's Disease.

Authors:  Yuanchu Zheng; Zhenwei Yu; Jiajia Zhao; Huihui Cai; Zhan Wang; Xuemei Wang; Tao Feng
Journal:  Front Aging Neurosci       Date:  2022-03-28       Impact factor: 5.750

6.  Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease.

Authors:  Juan F Reyes; Sara Ekmark-Léwen; Marina Perdiki; Therése Klingstedt; Alana Hoffmann; Emilia Wiechec; Per Nilsson; K Peter R Nilsson; Irina Alafuzoff; Martin Ingelsson; Martin Hallbeck
Journal:  Acta Neuropathol Commun       Date:  2021-03-20       Impact factor: 7.801

7.  A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients.

Authors:  Cláudia M Deus; Susana P Pereira; Teresa Cunha-Oliveira; José Teixeira; Rui F Simões; Fernando Cagide; Sofia Benfeito; Fernanda Borges; Nuno Raimundo; Paulo J Oliveira
Journal:  Redox Biol       Date:  2021-06-08       Impact factor: 11.799

Review 8.  Could Small Heat Shock Protein HSP27 Be a First-Line Target for Preventing Protein Aggregation in Parkinson's Disease?

Authors:  Javier Navarro-Zaragoza; Lorena Cuenca-Bermejo; Pilar Almela; María-Luisa Laorden; María-Trinidad Herrero
Journal:  Int J Mol Sci       Date:  2021-03-16       Impact factor: 5.923

Review 9.  Fermented Soy Products: Beneficial Potential in Neurodegenerative Diseases.

Authors:  Chan Ho Jang; Jisun Oh; Ji Sun Lim; Hyo Jung Kim; Jong-Sang Kim
Journal:  Foods       Date:  2021-03-18

Review 10.  Cardiac Changes in Parkinson's Disease: Lessons from Clinical and Experimental Evidence.

Authors:  Lorena Cuenca-Bermejo; Pilar Almela; Javier Navarro-Zaragoza; Emiliano Fernández Villalba; Ana-María González-Cuello; María-Luisa Laorden; María-Trinidad Herrero
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.